Domestic and foreign funds increase holdings in four major Indian pharmaceutical companies

Foreign and domestic institutional investors have raised their stakes across four prominent Indian pharmaceutical companies, pointing to rising market confidence in the sector. Gujarat Themis Biosyn saw foreign institutional investor ownership rise from 1.76% to 3.8% and domestic institutional investor ownership jump from 1.17% to 12.65% over the September quarter. The company posted first-quarter revenue of 43.8 crore rupees, marking a 22.1% year-on-year increase, while profit after tax also grew 22.1% to 11.1 crore rupees. Its recent initiatives include overseas brand acquisitions, manufacturing upgrades in Japan, and a hybrid power plant in Gujarat for captive energy use. Cipla recorded marginal increases in institutional backing, with foreign institutional investors moving from 20.20% to 20.24% and domestic funds raising their stake from 34.35% to 34.61%. Management anticipates continued North American growth through four upcoming product launches, including three respiratory assets. The US food and drug administration recently conducted inspections at its Goa and New York facilities, issuing minor observations or voluntary action statuses. Torrent Pharmaceuticals experienced foreign holdings climb from 15.44% to 17.22% and domestic holdings go from 9.73% to 13.37%. Its consolidated first-quarter revenue reached 4,921 crore rupees, up 55%, aided by the completion of the JB Chemicals merger in July. Rubicon Research also attracted higher institutional capital, with foreign funds increasing their share from 7.52% to 9.01% and domestic funds rising from 9.43% to 15.73%. Rubicon reported first-quarter revenue of 534.3 crore rupees, up 52%, alongside a profit after tax of 84.8 crore rupees driven partly by an insurance claim. Analysts advise retail buyers to study individual company valuations, debt levels, research spending, and regulatory hurdles rather than following institutional buying blindly.

Context

Institutional investors like mutual funds and foreign funds often take large positions in specific market sectors based on long-term earnings growth potential. However, retail buyers have different financial goals and risk limits compared to large institutional funds. Examining core business fundamentals remains essential before making any personal financial commitment in the stock market.